Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1841_Библиотеки_им_академика_М_И_Перельмана.pdf
INDEX
313
spleen-preserving distal
pancreatectomy 45–9
pancreatic abscess 17
pancreatic biopsy 64 , 65
pancreatic cysts 41–5
investigation and management 45
malignancy or malignant potential 45
origins 41–5, 42
pseudocyst vs cystic tumour 43
pancreatic duct (of Wirsung) 38
pancreatic epithelial tumours, malignant
potential 57
pancreatic mass, investigation/treatment
59 , 60
pancreatic necrosis 16–17
pancreatic surgery
bilirubin levels 58
development history 82
laparoscopic 86–7
see also pancreatectomy
pancreatic trauma 28–36
classification of injuries 30, 30
delayed presentation 33
ductal injury 32
fistulae 34–6
established fistulae 36
management 35
management 29
conservative management 31
surgical management 31–3, 31–3
pancreatic tumours 36–87
adenocarcinoma 56–87, 57 , 59–61
biliary bypass procedure
(hepaticojejunostomy) 65–72, 66–71
determining operability 61 , 62–5, 62–4
duodenal bleeding 95–6
laparoscopic pancreatic surgery 86–7
pancreaticoduodenectomy (Whipple’s
procedure) 72–86, 73–82 , 86
benign (non-neuroendocrine) lesions 40–1,
40
biopsy 64 , 65
carcinoma of head, management 86
cystic tumours 41–5, 41–5
distal pancreatectomy 43–51
for malignant disease 49–51, 50 , 52
epithelial tumours 57
malignant potential 57
gastroenterostomy 65–72
investigation/treatment flow charts 59 , 60
lymph node involvement 39
neuroendocrine tumours of pancreas 51–6,
53–6
pseudocyst vs cystic tumour 43
spleen-preserving distal pancreatectomy for
benign disease 45–9, 46–8
surgical anatomy 38–9, 39
pancreaticocystgastrostomy 8–10, 11–13
pancreaticocystjejunostomy 10–15, 14
excision biopsy 13
pancreaticoduodenectomy
adenocarcinoma 33 , 72–86, 73–82 , 86
contraindications 65
pancreatitis, acute 2–18
ascites 15
bile duct stones 4–5
Cambridge Marseille classification 2
causes 4–7
abscess 17
alcohol-related 5–6
gallstones 4–5
compartment syndrome 15–16
dilated bile duct 260–3, 262
inflammatory masses 7
laparostoma 16, 16
management 3
pancreatic necrosis 16–17
pleural effusions 15
pseudocysts 7–15
minimally invasive treatment 8–15, 9–11
pancreaticocystgastrostomy 8–10, 11–13
pancreaticocystjejunostomy 10–15, 14
recurrent 6
retroperitoneal bleeding 17–18
pancreatitis, chronic 18–28
assessment 19
focal disease 23–4
primary sclerosing pancreatitis 253–5
strictures 23–4
surgical treatment
end-stage disease with/without previous
surgery 24–6
expanded head 24
large duct disease 21–3
pancreaticodochogastrostomy 22–3, 22–3
schema 20
small duct disease 24
total pancreatectomy and islet cell
transplantation 25–8, 27
percutaneous transhepatic cholangiography
(PTC) 235
peritoneo-venous shunting, ascites 169–74
PET scanning, colorectal carcinoma liver
metastases 155–7, 164
pleural effusions
acute pancreatitis 15
pancreatitis, acute 15
polycystic liver disease 204–7
cyst deroofing 206
fenestration resections 206–7
treatment 204–7, 205–7
polydioxanone (PDS) 9
polyps
bile duct bladder 243–4
biliary tract 257
gallbladder 243–4
INDEX
314
portal hypertension 164–7
causes 166
schistosomiasis 185
Child–Pugh classification 166
management, and complications 167–8
splenic vein thrombosis 192–3, 193
portal vein
embolization 135–7, 137–8
right and left anomalies 106
portosystemic shunts 187–92
portocaval H-graft technique 188–91,
188–90
TIPS 191–2
transjugular intrahepatic portosystemic
shunt (TIPS) 191–2
positron emission tomography (PET)
scanning 155–7, 164
postcholecystectomy syndrome 242
Pringle manoeuvre, hepatoduodenal
ligament 110 , 114, 219, 220
pseudocysts
acute pancreatitis 7–15
minimally invasive treatment 8–15, 9–11
pancreaticocystgastrostomy 8–10, 11–13
pancreaticocystjejunostomy 10–15, 14
problems 14
Roux-en-Y drainage 14
retroperitoneal bleeding 17–18
Roux loop 14, 68
hepatic ducts 279
segment III bypass 280, 280–1
Roux-en-Y anastomosis
access limbs 271–3, 272
left bile duct 251
postsurgical intrahepatic stones 259
pseudocyst 14
reconstruction 33
sclerosing cholangitis 253–5
prevalence 253
sclerotherapy, oesophageal varices 175–9, 178
Sengstaken–Blakemore tube, balloon
tamponade 181–5, 181–3 , 185
sphincter of Oddi, dyskinesia/
dysfunction 263
sphincterotomy, trauma to biliary tract
266, 268
spleen-preserving distal pancreatectomy 45–9
splenectomy 192, 193
indications and consequences 52
splenic artery and vein 49, 50
splenic vein thrombosis 192–3, 193
superior mesenteric artery (SMA) 15, 38–9
anomalous origin of the hepatic artery 39
surgery to 79
superior mesenteric vein (SMV) 38–9
T-tube
cholangiography 233–5
pancreaticodochogastrostomy 22–3
preparation 231
tissue glues 154
total parenteral nutrition (TPN) 7
transjugular intrahepatic portosystemic
shunt (TIPS) 191–2
trauma
biliary tract 266–70
gallbladder surgery 264–6, 265
iatrogenic 264–6
impacted baskets 268–70, 270
late presentation 265–6
liver trauma 106–11, 107
tumours, bile duct bladder 243–51
tyrosine kinase inhibitors 160
variceal bleeding, management 175, 176–7
Whipple’s procedure see
pancreaticoduodenectomy
WHO classifications, neuroendocrine
tumours of pancreas 51, 53
xanthogranulomatous cholecystitis 219